HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Marc Idée Selected Research

gadodiamide (Omniscan)

1/2017Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.
8/2015Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats.
12/2014Safety profiles of gadolinium chelates in juvenile rats differ according to the risk of dissociation.
1/2013Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
4/2012Skin gadolinium following use of MR contrast agents in a rat model of nephrogenic systemic fibrosis.
2/2011Clinical, biological, and skin histopathologic effects of ionic macrocyclic and nonionic linear gadolinium chelates in a rat model of nephrogenic systemic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Marc Idée Research Topics

Disease

9Nephrogenic Fibrosing Dermopathy
11/2014 - 06/2008
5Renal Insufficiency (Renal Failure)
12/2021 - 08/2011
3Hepatocellular Carcinoma (Hepatoma)
01/2018 - 12/2013
3Inflammation (Inflammations)
01/2013 - 01/2006
2Body Weight (Weight, Body)
01/2022 - 01/2018
2Necrosis
04/2015 - 02/2011
2Fibrosis (Cirrhosis)
11/2014 - 01/2013
2Hypoxia (Hypoxemia)
04/2010 - 07/2002
1Amyloid Plaque
02/2017
1Chronic Renal Insufficiency
01/2017
1Osteoporosis
08/2015
1Liver Neoplasms (Liver Cancer)
04/2015
1Neoplasms (Cancer)
04/2015
1Alopecia (Baldness)
12/2014
1Hyperpigmentation
12/2014
1Anaphylaxis (Anaphylactic Shock)
07/2008
1Vascular System Injuries
06/2008
1Hypersensitivity (Allergy)
06/2005

Drug/Important Bio-Agent (IBA)

13GadoliniumIBA
12/2021 - 06/2008
9Contrast MediaIBA
01/2018 - 06/2005
6gadodiamide (Omniscan)FDA Link
01/2017 - 02/2011
3AdenineFDA LinkGeneric
12/2021 - 01/2013
3Ethiodized Oil (Ethiodol)FDA Link
01/2018 - 12/2013
2gadopiclenolIBA
01/2022 - 12/2021
2Pharmaceutical PreparationsIBA
01/2018 - 04/2015
2ferric oxide (iron oxide)IBA
02/2017 - 01/2006
2CollagenIBA
11/2011 - 02/2011
1gadobenic acid (gadobenate dimeglumine)FDA Link
01/2022
1EmulsionsIBA
01/2018
1CurcuminIBA
02/2017
1A-factor (Streptomyces)IBA
01/2017
1Radio-Opaque acrylic resinIBA
04/2015
1gadoterate meglumineIBA
04/2012
1gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
02/2011
1Biological ProductsIBA
02/2011
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2010
1CalciumIBA
06/2008
1ErythropoietinFDA Link
06/2008
1Phosphorus (Red Phosphorus)IBA
06/2008
1Interleukin-2 (IL2)IBA
06/2005
1Ioxaglic Acid (Ioxaglate Meglumine)FDA Link
07/2002
1iodixanol (Visipaque)FDA Link
07/2002
1Theophylline (Theon)FDA LinkGeneric
07/2002
1Purinergic P1 Receptor AntagonistsIBA
07/2002

Therapy/Procedure

1Ovariectomy (Oophorectomy)
08/2015
1Drug Therapy (Chemotherapy)
04/2015
1Therapeutics
04/2015
1Transplantation
04/2015
1Catheters
04/2015
1Injections
08/2011